Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value: $212M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IONS | IONIS PHARMACEUTICALS INC | 505,007 | $17.66M | 8.3% | $39.21 | -4.7% | COM | 462222100 |
| CYTK | CYTOKINETICS INC | 360,000 | $16.93M | 8.0% | $51.77 | +0.3% | COM NEW | 23282W605 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,787,003 | $15.14M | 7.1% | $11.31 | -8.4% | COM | 483497103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 750,000 | $14.38M | 6.8% | $18.37 | +18.3% | COM | 92790C104 |
| PLRX | PLIANT THERAPEUTICS INC | 1,055,000 | $13.89M | 6.5% | $16.18 | -15.6% | COM | 729139105 |
| ABVX | ABIVAX SA | 1,648,523 | $12.07M | 5.7% | $12.06 | — | SPONSORED ADS | 00370M103 |
| — | DYNAVAX TECHNOLOGIES CORP | 860,000 | $10.98M | 5.2% | $11.86 | — | COM NEW | 268158201 |
| NGNE | NEUROGENE INC | 442,761 | $10.12M | 4.8% | $14.51 | +156.4% | COM | 64135M105 |
| EOLS | EVOLUS INC | 895,524 | $9.887M | 4.7% | $9.65 | +45.7% | COM | 30052C107 |
| XENE | XENON PHARMACEUTICALS INC | 245,272 | $9.615M | 4.5% | $41.35 | 0.0% | COM | 98420N105 |
| — | UNICYCIVE THERAPEUTICS INC | 10,980,000 | $8.72M | 4.1% | $0.49 | — | COM | 90466Y103 |
| ZURA | ZURA BIO LTD | 3,170,194 | $7.925M | 3.7% | $6.43 | -44.6% | CLASS A ORD SHS | G9TY5A101 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 3,009,392 | $7.072M | 3.3% | $4.32 | — | SPON ADS | 05280R100 |
| JSPR | JASPER THERAPEUTICS INC | 322,380 | $6.892M | 3.2% | $17.76 | +17.2% | COM NEW | 471871202 |
| — | MERUS N V | 158,092 | $6.648M | 3.1% | $52.47 | — | COM | N5749R100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 275,000 | $5.995M | 2.8% | $22.14 | +16.1% | COM | 252828108 |
| BBOT | HELIX ACQUISITION CORP II | 500,000 | $5.25M | 2.5% | $10.35 | +1.5% | CL A ORD SHS | G4444H101 |
| UPB | UPSTREAM BIO INC | 300,000 | $4.932M | 2.3% | $22.33 | 0.0% | COM | 91678A107 |
| CNTX | CONTEXT THERAPEUTICS INC | 4,683,711 | $4.918M | 2.3% | $1.72 | +0.4% | COM | 21077P108 |
| VYGR | VOYAGER THERAPEUTICS INC | 826,751 | $4.688M | 2.2% | $7.91 | — | COM | 92915B106 |
| ORKA | ORUKA THERAPEUTICS INC | 228,803 | $4.436M | 2.1% | $34.79 | -29.9% | COM | 687604108 |
| MREO | MEREO BIOPHARMA GROUP PLC | 1,150,000 | $4.025M | 1.9% | $3.50 | — | SPON ADS | 589492107 |
| RZLT | REZOLUTE INC | 621,894 | $3.047M | 1.4% | $5.04 | 0.0% | COM NEW | 76200L309 |
| — | PROMIS NEUROSCIENCES INC | 2,645,128 | $2.507M | 1.2% | $1.25 | — | COM NEW | 74346M406 |
| — | OPTINOSE INC | 370,269 | $2.473M | 1.2% | $6.68 | — | COM NEW | 68404V209 |
| URGN | UROGEN PHARMA LTD | 187,843 | $2.001M | 0.9% | $15.87 | -24.6% | COM | M96088105 |